Government Health Authorities: 26-Year-Old’s Death ‘Probably’ Due To Pfizer COVID Vaccine

(Republican Party News) – A new report from WND says that New Zealand officials have come out and admitted that the death of a 26-year-old man from the country was due to myocarditis, which has been linked to the Pfizer/BioNTech vaccine.

Anyone who has been paying attention to the coverage of these vaccines over the course of the last year should not at all be surprised to hear of a death related to the side effects of the jab, as it’s been clearly demonstrated in the data that has surfaced time and again through scientific studies and reports.

“With the current available information, the board has considered that the myocarditis was probably due to vaccination in this individual,” a COVID-19 Vaccine Independent Safety Monitoring Board went on to say in a statement, according to a report from Reuters.

“The Board noted that Covid-19 infection can itself be a cause of myocarditis, as well as other serious illnesses, and it remains safer to be vaccinated than to be infected with the virus,” the board said, according to Bloomberg.

Myocarditis, which is an inflammation of the heart, is actually a very rare disease, which is why this possible side effect has become such a hotly debated topic when it comes to discussions of the safety of the Moderna and Pfizer vaccines.

Links have been discovered between the Moderna vaccine and myocarditis in young men in several European countries just this year, leading many of them to take action and ban the Moderna shot for individuals under 30.

“Sweden, Finland, Denmark and Iceland were among those either formally or informally steering young males away from the Moderna shot, according to Reuters. Japan has also issued warnings about the link between the vaccine and the disease,” WND said in its report.

The death of the 26-year-old man is actually the second vaccine-linked death to occur in New Zealand. Back in August, a woman also passed away due to myocarditis attributed to the COVID vaccine.

“The vaccine safety board in New Zealand has said there are two other myocarditis deaths being investigated for links to the vaccine, although it indicated one death — that of a man in his 60s — was not considered likely to be linked to the shot,” the report continued.

The death of the 13-year-old is still currently under investigation.

The safety board in New Zealand has stated that despite these known myocarditis cases, they still recommend people take the vaccine.

Back in June of this year, the Food and Drug Administration put a warning on the Pfizer vaccine stating that there was a potential risk for myocarditis associated with taking it, according to a report from CNBC.

“The risk of myocarditis and pericarditis appears to be very low given the number of vaccine doses that have been administered,” acting FDA Commissioner Janet Woodcock remarked in a statement put out at the time. Pericarditis is a condition that inflames the tissue surrounding the heart.

“Last week, the federal Centers for Disease Control and Prevention said it has received reports of eight cases of myocarditis in children between the ages of 5 and 11 who received the Pfizer shot, according to Fox Business. The CDC called the cases mild,” WND said.

A study of 139 patients under the age of 21, which was just released last week, has reported that in most cases the symptoms from myocarditis were mild, according to a report published by the Daily Mail.

Well, no offense, but even mild symptoms of heart inflammation sounds pretty darn serious and like something the vast majority of Americans would probably like to avoid. Just saying.

The study in question involved researchers working at the University of Utah, Boston Children’s Hospital, and other institutions. The study discovered that around 19 percent of cases required the patient to receive intensive care, however, those that were hospitalized only stayed two days on average. None of the patients involved in the study died.

“These data suggest that most cases of suspected COVID-19 vaccine-related myocarditis in people younger than 21 are mild and resolve quickly,” Dr. Dongngan Truong, a pediatrician at the University of Utah and first author on the study went on to say.

“We were very happy to see that type of recovery,” he remarked. “However, we are awaiting further studies to better understand the long-term outcomes of patients who have had COVID-19 vaccination-related myocarditis.”

Copyright 2021.


Please enter your comment!
Please enter your name here